Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2014 | 07-2013 | 07-2012 | 07-2011 | 07-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,977 | -18,237 | -39,269 | -12,960 | -22,233 |
| Depreciation Amortization | 3,971 | 4,605 | 4,477 | 4,469 | 4,269 |
| Income taxes - deferred | -18 | -759 | -1,762 | 17 | -45 |
| Accounts receivable | -3,224 | -2,606 | -4,210 | -6,537 | -3,844 |
| Accounts payable and accrued liabilities | -226 | -514 | 1,031 | 1,462 | 2,348 |
| Other Working Capital | 338 | -539 | 81 | -5,163 | 300 |
| Other Operating Activity | 7,439 | 8,034 | 33,680 | 10,386 | 5,741 |
| Operating Cash Flow | $-1,697 | $-10,016 | $-5,972 | $-8,326 | $-13,464 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 10,000 | 14,807 | 18,497 |
| PPE Investments | -838 | -988 | -1,364 | -1,223 | -3,251 |
| Other Investing Activity | 5 | 17 | -1,175 | -45 | 81 |
| Investing Cash Flow | $-833 | $-971 | $7,461 | $13,539 | $15,327 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 78,814 | 13,360 | 0 | N/A | N/A |
| Debt Repayment | -374 | -274 | -154 | -68 | 0 |
| Common Stock Issued | 11,542 | 1,825 | 0 | N/A | N/A |
| Other Financing Activity | -79,065 | -10,096 | 0 | 0 | 0 |
| Financing Cash Flow | $10,917 | $4,815 | $-154 | $-68 | $0 |
| Exchange Rate Effect | 61 | 103 | -420 | 257 | -33 |
| Beginning Cash Position | 9,007 | 15,076 | 14,161 | 8,759 | 6,929 |
| End Cash Position | 17,455 | 9,007 | 15,076 | 14,161 | 8,759 |
| Net Cash Flow | $8,448 | $-6,069 | $915 | $5,402 | $1,830 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,697 | -10,016 | -5,972 | -8,326 | -13,464 |
| Capital Expenditure | -838 | -988 | -1,364 | -1,223 | -3,251 |
| Free Cash Flow | -2,535 | -11,004 | -7,336 | -9,549 | -16,715 |